Toutes les études
RecrutementInterventionnel

Advanced hybrid procedure for recurring atrial fibrillation

Atrial fibrillation (AF) is a common condition that causes an irregular and often fast heartbeat. Sometimes, standard catheter treatments to correct this do not last, and uncomfortable symptoms return. This study, called HALO-AF, is taking place across three London NHS hospitals. It is designed for adults whose AF has come back after having one or two previous ablation procedures. Researchers want to find out which of two approaches works better: repeating the standard ablation from inside the heart, or using an advanced 'hybrid' technique. The hybrid technique treats both the inside and outside of the heart and seals off a small pouch where blood clots can form. Participants are randomly placed into one of the two treatment groups. Both options are currently available on the NHS. Taking part involves routine heart scans, blood tests, and check-ups over about one year to monitor your heart and overall wellbeing.

En un coup d'œil

Statut
Recrutement
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Objectif d'inscription
126
Démarrer
15 Oct 2026
Achèvement estimé
15 Oct 2028

De quoi parle cette étude ?

Atrial fibrillation (AF) happens when the electrical signals controlling your heartbeat become chaotic. This causes the upper chambers of the heart to quiver rather than pump properly, leading to symptoms like fluttering in the chest, extreme tiredness, dizziness, and breathlessness. While many people are treated with catheter ablation—a keyhole procedure that gently scars the inside of the heart tissue to block faulty signals—the irregular rhythm can sometimes return over time.

The HALO-AF study is designed to help doctors find the best next step when persistent AF comes back. It compares two methods. The first is a repeat standard catheter ablation, performed from the inside of the heart. The second is an advanced 'hybrid' ablation. This combines treatment to the outside of the heart through a tiny cut, treatment inside the heart, and closure of the left atrial appendage (a small heart pouch where blood clots can form during AF).

Both procedures are already used in the NHS, but doctors need clearer evidence about which one gives better, longer-lasting results. By comparing these two strategies, the study hopes to discover which approach is safer, better at keeping the heart in a normal rhythm, and most helpful for improving patients' daily quality of life.

Points clés

  • Compares standard repeat catheter ablation with an advanced hybrid procedure.
  • Aimed at adults whose persistent atrial fibrillation has returned after past treatments.
  • Takes place across three specialist NHS hospitals in London.
  • Treatment groups are chosen at random by a computer.
  • Includes routine check-ups and heart scans over a 12-month follow-up period.

Qui peut être éligible ?

This trial is for adults aged 18 and older who have persistent or long-standing persistent atrial fibrillation that causes ongoing symptoms. To be considered, you must have already had one or two catheter ablation procedures in the past that did not permanently control your irregular rhythm.

You will not be able to take part if you have had open heart surgery in the past (such as a heart bypass or heart valve replacement), or if you have previously had a device fitted to close the heart's small pouch.

Additionally, people who have had a stroke or heart attack within the last three months, or who have very severe heart failure symptoms, are not eligible for safety reasons. Your hospital team will perform standard heart scans to confirm whether your heart size and shape are suitable for the study.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. You are aged 18 or over.
  2. You have persistent or long-standing atrial fibrillation that causes symptoms.
  3. You have had 1 or 2 catheter ablations in the past.
  4. You have never had open heart surgery (such as a bypass or valve operation).
  5. You have not had a heart attack or stroke within the past 3 months.
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you take part, you will first have standard health checks to make sure the trial is safe for you. These include an electrocardiogram (ECG) to check your heart rhythm, routine blood tests, an ultrasound scan of your heart (echocardiogram), and potentially a CT scan.

Eligible patients are randomly allocated by a computer to receive either the standard catheter ablation or the hybrid ablation procedure. Neither you nor your doctor can choose the group, ensuring the study results are fair and reliable. After your procedure, you will stay in touch with the hospital research team for around 12 months. During this year, you will attend routine follow-up visits, undergo regular heart monitoring, and fill out short questionnaires about your symptoms and daily wellbeing. These visits are very similar to the care you would normally receive after heart rhythm treatment.

Risques et avantages potentiels

Taking part may help improve your heart rhythm and symptoms, and you will receive close, expert monitoring from a specialist heart rhythm team throughout the year. The findings may also help future NHS patients with difficult-to-treat AF. Because both treatments involve invasive heart procedures, there are potential risks such as bleeding, infection, or heart rhythm complications; your doctor will explain these carefully before you agree to join. Taking part is completely voluntary. You can change your mind and withdraw at any time without your regular NHS medical care being affected.

Emplacements (3)

  • Hôpital Royal Brompton
    Approximatif
    London, England
  • St Thomas' Hospital
    Approximatif
    London, England
  • Hôpital Harefield
    Approximatif
    Uxbridge, England

Questions fréquentes

What is the difference between standard and hybrid ablation?

Standard ablation treats the faulty electrical areas only from the inside of the heart using thin tubes. Hybrid ablation treats both the inside and outside of the heart, and also seals a small pouch where blood clots might form.

Can I choose which treatment I receive?

No. A computer assigns you to one of the two groups by chance. This random process ensures the comparison between treatments is completely fair and scientifically valid.

Does taking part cost anything?

No. All treatments, scans, and tests are provided as part of NHS clinical research, so there is no cost to you.

Where does the study take place?

The trial is based in London across three specialist NHS hospitals: Royal Brompton Hospital, Harefield Hospital, and St Thomas' Hospital.

What happens if I decide to leave the trial?

You are free to leave the study at any point. If you decide to stop, your doctors will continue to care for you using the best available standard NHS treatments.

Comment en savoir plus

Ines Kralj-Hans

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Advanced hybrid procedure for recurring atrial fibrillation… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.